Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Tocilizumab and other biological drugs were particularly efficacious in lowering overall hemostatic potential, mitigating blood clot risks.

Early Control of Rheumatoid Arthritis Improves Hemostatic Imbalance

Around 37% of those had never used a bDMARD reached sustained DMARD-free remission at 5 years, 

DMARD-Free Remission Feasible for bDMARD-Naive Patients for RA 

Despite improvements in PROs and disease activity, no statistically significant changes have been seen on blood biomarker analysis. 

Cannabinoid-Based Formula Demonstrates Proof-of-Concept for Treating RA 

Cell therapy, particularly CAR-T, is expanding into autoimmune diseases like lupus and multiple sclerosis. While promising, safety, efficacy, and broad applicability remain uncertain.

Leveling Up: Cell Therapy Research Expands Horizons in Autoimmune Disease

Emapalumab may improve outcomes in patients with MAS whose disease didn’t respond to steroid therapy and mitigate the need for more toxic therapies.

Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome

Tesser discussed the background of the phase 3 RESET-RA trial and efficacy findings.

John Tesser, MD: Improving Outcomes in RA With Vagus Nerve Stimulation

Data from 2 studies presented at ACR 2024 demonstrate the potential of AI to improve access to quality rheumatological assessments. 

AI Assessments, Robotics Perform to Rheumatologist Levels in Joint Assessment 

Over one-third of participants had had inadequate responses or intolerance to at least 3 prior b/tsDMARDs.

Vagus Nerve Stimulation Yields Responses in Refractory Rheumatoid Arthritis

However, fewer patients experienced flares in the tofacitinib group than in the placebo group, among other positive findings.

Tofacitinib Not Superior to Placebo in Systemic Juvenile Arthritis Double-Blind Trial

Just discussed data from 2 studies demonstrating efficacy of AI assessment compared to clinician assessment.

Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment

The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.